Hallmarks of atopic skin mimicked in vitro by means of a skin disease model based on FLG knock-down

ATLA Alternatives to Laboratory Animals

Volumn 39, Issue 5, 2011, Pages 471-480

  Küchler, Sarah ^a   Henkes, Dominika ^a   Eckl, Katja Martina ^b   Ackermann, Katharina ^a   Plendl, Johanna ^a   Korting, Hans Christian ^c   Hennies, Hans Christian ^b   Schäfer Korting, Monika ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Atopic dermatitis; Filaggrin; In vitro skin disease model; siRNA; Skin barrier function

Indexed keywords

FILAGGRIN; INTERLEUKIN 6; INTERLEUKIN 8; LACTATE DEHYDROGENASE;

ARTICLE; ATOPIC DERMATITIS; CELL DIFFERENTIATION; CONTROLLED STUDY; ELECTRODERMAL RESPONSE; EPIDERMIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; KERATINOCYTE; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN ABSORPTION; SKIN IRRITATION; SKIN PERMEABILITY;

EID: 82455181520     PISSN: 02611929     EISSN: None     Source Type: Journal    
DOI: 10.1177/026119291103900508     Document Type: Article

References (38)

1. Bieber, T. (2008). Atopic dermatitis. New England Journal of Medicine 358, 1483-1494.
2. Williams, H.C. (2005). Clinical practice. Atopic dermatitis. New England Journal of Medicine 352, 2314-2324.
3. He, R., Oyoshi, M.K., Garibyan, L., Kumar, L., Ziegler, S.F. & Geha, R.S. (2008). TSLP acts on infiltrating effector T cells to drive allergic skin inflammation. Proceedings of the National Academy of Sciences of the USA 105, 11,875-11,880.
4. Leung, D.Y. & Bieber, T. (2003). Atopic dermatitis. Lancet 361, 151-160. (Pubitemid 36092023)
5. Ziegler, S.F. & Artis, D. (2010). Sensing the outside world: TSLP regulates barrier immunity. Nature Immunology 11, 289-293.
6. Palmer, C.N., Irvine, A.D., Terron-Kwiatkowski, A., Zhao, Y., Liao, H., Lee, S.P., Goudie, D.R., Sandilands, A., Campbell, L.E., Smith, F.J., O'Regan, G.M., Watson, R.M., Cecil, J.E., Bale, S.J., Compton, J.G., DiGiovanna, J.J., Fleckman, P., Lewis-Jones, S., Arseculeratne, G., Sergeant, A., Munro, C.S., El Houate, B., McElreavey, K., Halkjaer, L.B., Bisgaard, H., Mukhopadhyay, S. & McLean, W.H. (2006). Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nature Genetics 38, 441-446.
7. Jung, T. & Stingl, G. (2008). Atopic dermatitis: Therapeutic concepts evolving from new pathophysiol ogic insights. Journal of Allergy & Clinical Immunology 122, 1074-1081.
8. O'Regan, G.M. & Irvine, A.D. (2010). The role of filaggrin in the atopic diathesis. Clinical & Experimental Allergy 40, 965-972.
9. Sandilands, A., O'Regan, G.M., Liao, H., Zhao, Y., Terron-Kwiatkowski, A., Watson, R.M., Cassidy, A.J., Goudie, D.R., Smith, F.J., McLean, W.H. & Irvine, A.D. (2006). Prevalent and rare mutations in the gene encoding filaggrin cause ichthyosis vulgaris and predispose individuals to atopic dermatitis. Journal of Investigative Dermatology 126, 1770-1775. (Pubitemid 44086511)
10. Elias, P.M. (2010). Therapeutic implications of a barrier-based pathogenesis of atopic dermatitis. Annals of Dermatology 22, 245-254.
11. Fallon, P.G., Sasaki, T., Sandilands, A., Campbell, L.E., Saunders, S.P., Mangan, N.E., Callanan, J.J., Kawasaki, H., Shiohama, A., Kubo, A., Sundberg, J.P., Presland, R.B., Fleckman, P., Shimizu, N., Kudoh, J., Irvine, A.D., Amagai, M. & McLean, W.H. (2009). A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen priming. Nature Genetics 41, 602-608.
12. Scharschmidt, T.C., Man, M.Q., Hatano, Y., Crumrine, D., Gunathilake, R., Sundberg, J.P., Silva, K.A., Mauro, T.M., Hupe, M., Cho, S., Wu, Y., Celli, A., Schmuth, M., Feingold, K.R. & Elias, P.M. (2009). Filaggrin deficiency confers a paracellular barrier abnormality that reduces inflammatory thresholds to irritants and haptens. Journal of Allergy & Clinical Immunology 124, 496-506e6.
13. Jin, H., He, R., Oyoshi, M. & Geha, R.S. (2009). Animal models of atopic dermatitis. Journal of Investigative Dermatology 129, 31-40.
14. Shiohara, T., Hayakawa, J. & Mizukawa, Y. (2004). Animal models for atopic dermatitis: Are they relevant to human disease? Journal of Dermatological Science 36, 1-9. (Pubitemid 39370020)
15. Simonsen, L. & Fullerton, A. (2007). Development of an in vitro skin permeation model simulating atopic dermatitis skin for the evaluation of dermatological products. Skin Pharmacology & Physiology 20, 230-236. (Pubitemid 47312677)
16. Carlson, M.W., Alt-Holland, A., Egles, C. & Garlick, J.A. (2008). Three-dimensional tissue models of normal and diseased skin. Current Protocols in Cell Biology 41, 19.9.1-19.9.17.
17. Kandárová, H., Liebsch, M., Schmidt, E., Genschow, E., Traue, D., Spielmann, H., Meyer, K., Steinhoff, C., Tornier, C., De Wever, B. & Rosdy, M. (2006). Assessment of the skin irritation potential of chemicals by using the SkinEthic reconstructed human epidermal model and the common skin irritation protocol evaluated in the ECVAM skin irritation validation study. ATLA 34, 393-406. (Pubitemid 44369441)
18. Spielmann, H., Hoffmann, S., Liebsch, M., Botham, P., Fentem, J.H., Eskes, C., Roguet, R., Cotovio, J., Cole, T., Worth, A., Heylings, J., Jones, P., Robles, C., Kandárová, H., Gamer, A., Remmele, M., Curren, R., Raabe, H., Cockshott, A., Gerner, I. & Zuang, V. (2007). The ECVAM international validation study on in vitro tests for acute skin irritation: Report on the validity of the EPISKIN and EpiDerm assays and on the Skin Integrity Function Test. ATLA 35, 559-601. (Pubitemid 351169735)
19. Schäfer-Korting, M., Bock, U., Diembeck, W., Düsing, H.J., Gamer, A., Haltner-Ukomadu, E., Hoffmann, C., Kaca, M., Kamp, H., Kersen, S., Kietzmann, M., Korting, H.C., Krächter, H.U., Lehr, C.M., Liebsch, M., Mehling, A., Müller-Goymann, C., Netzlaff, F., Niedorf, F., Rübbelke, M.K., Schäfer, U., Schmidt, E., Schreiber, S., Spielmann, H., Vuia, A. & Weimer, M. (2008). The use of reconstructed human epidermis for skin absorption testing: Results of the validation study. ATLA 36, 161-187. (Pubitemid 351861001)
20. Obrigkeit, D.H., Jugert, F.K., Beermann, T., Baron, J.M., Frank, J., Merk, H.F., Bickers, D.R. & Abuzahra, F. (2009). Effects of photodynamic therapy evaluated in a novel three-dimensional squamous cell carcinoma organ construct of the skin. Photochemistry & Photobiology 85, 272-278.
21. Oji, V., Eckl, K.M., Aufenvenne, K., Natebus, M., Tarinski, T., Ackermann, K., Seller, N., Metze, D., Nürnberg, G., Fölster-Holst, R., Schäfer-Korting, M., Hausser, I., Traupe, H. & Hennies, H.C. (2010). Loss of corneodesmosin leads to severe skin barrier defect, pruritus, and atopy: Unraveling the peeling skin disease. American Journal of Human Genetics 87, 274-281.
22. Mildner, M., Jin, J., Eckhart, L., Kezic, S., Gruber, F., Barresi, C., Stremnitzer, C., Buchberger, M., Mlitz, V., Ballaun, C., Sterniczky, B., Födinger, D. & Tschachler, E. (2010). Knockdown of filaggrin impairs diffusion barrier function and increases UV sensitivity in a human skin model. Journal of Investigative Dermatology 130, 2286-2294.
23. Gysler, A., Lange, K., Korting, H.C. & Schäfer-Korting, M. (1997). Prednicarbate biotransformation in human foreskin keratinocytes and fibroblasts. Pharmaceutical Research 14, 793-797. (Pubitemid 27281676)
24. Potteck, H., Nieuwenhuis, B., Lüth, A., van der Giet, M. & Kleuser, B. (2010). Phosphorylation of the immunomodulator FTY720 inhibits programmed cell death of fibroblasts via the S1P3 receptor subtype and Bcl-2 activation. Cellular Physiology & Biochemistry 26, 67-78.
25. Eckl, K.M., Alef, T., Torres, S. & Hennies, H.C. (2011). Full-thickness human skin models for congenital ichthyosis and related keratinization disorders. Journal of Investigative Dermatology 131, 1938-1942.
26. Anon. (2009). Human CXCL8/IL-8, 6pp. Abingdon, UK: R&D Systems Europe, Ltd. Available at: http:// www.rndsystems.com/pdf/dy208.pdf (Accessed 13.09.11).
27. Anon. (2009). Human IL-6, 6pp. Abingdon, UK: R&D Systems Europe, Ltd. Available at: http://www.rndsystems.com/pdf/dy206.pdf (Accessed 13.09.11).
28. Anon. (2005). Cytotoxicity Detection Kit (LDH), 20pp. Mannheim, Germany: Roche Applied Science. Available at: https://e-labdoc.roche.com/LFR-Public Docs/ras/11644793001-en-07.pdf (Accessed 13.09. 11).
29. Schäfer-Korting, M., Bock, U., Gamer, A., Haberland, A., Haltner-Ukomadu, E., Kaca, M., Kamp, H., Kietzmann, M., Korting, H.C., Krächter, H.U., Lehr, C.M., Liebsch, M., Mehling, A., Netzlaff, F., Niedorf, F., Rübbelke, M.K., Schäfer, U., Schmidt, E., Schreiber, S., Schröder, K.R., Spielmann, H. & Vuia, A. (2006). Reconstructed human epidermis for skin absorption testing: Results of the German prevalidation study. ATLA 34, 283-294. (Pubitemid 44105843)
30. Ackermann, K., Borgia, S.L., Korting, H.C., Mewes, K.R. & Schäfer-Korting, M. (2010). The Phenion full-thickness skin model for percutaneous absorption testing. Skin Pharmacology & Physiology 23, 105-112.
31. Elias, P.M., Hatano, Y. & Williams, M.L. (2008). Basis for the barrier abnormality in atopic dermatitis: Outside-inside-outside pathogenic mechanisms. Journal of Allergy & Clinical Immunology 121, 1337-1343.
32. O'Regan, G.M., Sandilands, A., McLean, W.H. & Irvine, A.D. (2008). Filaggrin in atopic dermatitis. Journal of Allergy & Clinical Immunology 122, 689-693.
33. Kerl, H., Garbe, C., Cerroni, L. & Wolff, H.H. (2003). Histopathologie der Haut, 970pp. Berlin, Germany: Springer-Verlag.
34. Tsai, T.F. & Maibach, H.I. (1999). How irritant is water? An overview. Contact Dermatitis 41, 311-314.
35. De Jongh, C.M., Verberk, M.M., Withagen, C.E., Jacobs, J.J., Rustemeyer, T. & Kezic, S. (2006). Stratum corneum cytokines and skin irritation response to sodium lauryl sulfate. Contact Dermatitis 54, 325-333. (Pubitemid 43886532)
36. Oyoshi, M.K., He, R., Kumar, L., Yoon, J. & Geha, R.S. (2009). Cellular and molecular mechanisms in atopic dermatitis. Advances in Immunology 102, 135-226.
37. Engelhart, K., El Hindi, T., Biesalski, H.K. & Pfitzner, I. (2005). In vitro reproduction of clinical hallmarks of eczematous dermatitis in organotypic skin models. Archives of Dermatological Research 297, 1-9. (Pubitemid 41380676)
38. Pariser, D. (2009). Topical corticosteroids and topical calcineurin inhibitors in the treatment of atopic dermatitis: Focus on percutaneous absorption. American Journal of Therapeutics 16, 264-273.